Press Releases

Featured Press Releases

BIO International Convention Returns to San Diego…

20,000+ biotech leaders gather with a shared mission: to improve lives SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today…

Learn more

BIO Statement on Veto of Prescription Drug…

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…

Learn more

BIO Statement on Resignation of FDA Commissioner…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…

Learn more

BIO Applauds Senate Passage of Opioid Crisis Response Act of 2018

September 17, 2018

“BIO’s member companies are committed to unleashing the power of scientific innovation to develop solutions that will lead to an America free of prescription opioid addiction. Today’s vote advances vital legislation that will help get new…

BIO Applauds Legislation to Spur Investment in Start-ups

September 12, 2018

Washington, DC (September 12, 2018) – The Biotechnology Innovation Organization (BIO) today applauded the introduction of the American Innovation Act of 2018 (H.R. 6756), which includes a provision that would protect investments in start-ups…

BIO Announces Programming for the 17th Annual BIO Investor Forum

September 4, 2018

Amidst a healthy investment climate for biotech companies, BIO announces programming for the 17th annual BIO Investor Forum

BIO Urges EPA to Help Boost America’s Rural Economy

August 20, 2018

On Friday, August 17, the Biotechnology Innovation Organization (BIO) urged the Environmental Protection Agency (EPA) to use its authority under the Renewable Fuel Standard (RFS) program to strengthen America’s biobased economy.

BIO Releases Statement on NGA’s Report on Prescription Drug Costs

August 10, 2018

Washington, DC (August 10, 2018) – Tom Dilenge, president of advocacy, law & public policy at the Biotechnology Innovation Organization (BIO), issued the following statement today after the National Governors Association (NGA) released a…

Congressman Tom Suozzi to Spotlight Scientific and Economic Development Advancements in New York

July 27, 2018

Congressman Tom Suozzi will join leaders of New York’s biotechnology community for a tour of Alexandria LaunchLabs on Monday, July 30, 2018 at 11:00 am.

BIO Wraps Up Transformative 2018 BIO World Congress in Philadelphia

July 19, 2018

Philadelphia (July 19, 2018) – The 15th annual BIO World Congress on Industrial Biotechnology concluded today at the Pennsylvania Convention Center in Philadelphia. The BIO World Congress continues to be the largest industrial…

BIO Announces Dr. Larry Walker as the Leadership and Legacy Award Recipient at the 2018 BIO World Congress

July 19, 2018

Philadelphia (July 19, 2018) –The Biotechnology Innovation Organization (BIO) today presented Dr. Larry Walker, co-editor in chief for the journal “Industrial Biotechnology,” with the third annual BIO Leadership and Legacy Award in Industrial…

BIO Applauds Advancement of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

July 19, 2018

Legislation would strengthen the pipeline and stockpile of medical countermeasures vital to our nation’s safety and defense

BIO Applauds House Passage of the JOBS and Investor Confidence Act of 2018

July 17, 2018

Washington, DC (July 17, 2018) – Today, the Biotechnology Innovation Organization (BIO) applauds the passage by the House of Representatives of the JOBS and Investor Confidence Act of 2018 (S. 488), or JOBS Act 3.0, in a widely bipartisan vote…